Last-Minute Changes To Senate Health Package Take Shape

By Rachel Cohrs
June 25, 2019 at 5:51 PM
Part of a bill introduced by Sens. Susan Collins (R-ME) and Tim Kaine (D-VA) that aims to increase transparency around the webs of patents that biologics manufacturers create to thwart biosimilar competition will be included in the Senate health committee’s bipartisan package on lowering health care costs, Collins’ office said Tuesday (June 25). Sens. Tina Smith (D-MN) and Mike Braun (R-IN) introduced an amendment that would alleviate generic drug makers’ concerns about the package, and Sen. Tammy Baldwin (D-WI) proposed...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.